Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.20)
# 3,541
Out of 4,876 analysts
501
Total ratings
31.08%
Success rate
-14.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Reiterates: Buy | $138 | $105.90 | +30.31% | 43 | Jun 25, 2025 | |
| EXEL Exelixis | Maintains: Buy | $40 → $47 | $43.48 | +8.10% | 8 | Jun 12, 2025 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $2.10 | +233.35% | 8 | Jun 4, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $14 → $12 | $7.14 | +68.07% | 11 | May 20, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $12 → $11 | $4.67 | +135.80% | 21 | May 19, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $44 → $41 | $8.80 | +365.91% | 4 | May 16, 2025 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $12 | $2.15 | +458.14% | 3 | May 16, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $39 → $40 | $20.80 | +92.31% | 4 | May 15, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $39 → $40 | $22.73 | +75.98% | 9 | May 14, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $73 → $72 | $36.88 | +95.23% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $10.34 | +112.87% | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $3.11 | +478.78% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.84 | +495.24% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $74 → $47 | $46.99 | +0.03% | 32 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.31 | +129.01% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.06 | +157.17% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $11.60 | +210.34% | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $7.91 | +26.50% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.69 | +197.40% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.50 | +185.71% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.24 | +61.29% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.03 | +385.44% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.19 | +575.11% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $2.43 | +394.85% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.39 | +1,322.59% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $12.21 | +6.47% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.95 | +414.14% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.39 | +261.01% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.29 | +387.06% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $9.23 | +138.48% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.20 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.80 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.19 | +824.37% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $6.33 | +3,059.56% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.23 | +8,607.01% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.61 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $3.50 | +4,185.71% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.35 | +1,529.63% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.04 | +576.33% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.34 | +370.09% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.09 | +262,443.76% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.76 | +564.89% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.32 | +460.34% | 1 | Jan 7, 2021 |
BioNTech SE
Jun 25, 2025
Reiterates: Buy
Price Target: $138
Current: $105.90
Upside: +30.31%
Exelixis
Jun 12, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $43.48
Upside: +8.10%
Immix Biopharma
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.10
Upside: +233.35%
Cogent Biosciences
May 20, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $7.14
Upside: +68.07%
Y-mAbs Therapeutics
May 19, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.67
Upside: +135.80%
Bicara Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $8.80
Upside: +365.91%
TuHURA Biosciences
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.15
Upside: +458.14%
Enliven Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $20.80
Upside: +92.31%
ArriVent BioPharma
May 14, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $22.73
Upside: +75.98%
Revolution Medicines
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $36.88
Upside: +95.23%
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $10.34
Upside: +112.87%
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $3.11
Upside: +478.78%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.84
Upside: +495.24%
Apr 30, 2025
Downgrades: Neutral
Price Target: $74 → $47
Current: $46.99
Upside: +0.03%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.31
Upside: +129.01%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $5.06
Upside: +157.17%
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $11.60
Upside: +210.34%
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $7.91
Upside: +26.50%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $2.69
Upside: +197.40%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.24
Upside: +61.29%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.03
Upside: +385.44%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.19
Upside: +575.11%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $2.43
Upside: +394.85%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.39
Upside: +1,322.59%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.21
Upside: +6.47%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.95
Upside: +414.14%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.39
Upside: +261.01%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.29
Upside: +387.06%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $9.23
Upside: +138.48%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.20
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.80
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.19
Upside: +824.37%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $6.33
Upside: +3,059.56%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.23
Upside: +8,607.01%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.61
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $3.50
Upside: +4,185.71%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.35
Upside: +1,529.63%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.04
Upside: +576.33%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.34
Upside: +370.09%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.09
Upside: +262,443.76%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.76
Upside: +564.89%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.32
Upside: +460.34%